Ethnic differences in CYP2C9*2 (Arg144Cys) and CYP2C9*3 (Ile359Leu) genotypes in Japanese and Israeli populations

This publication has 17 references indexed in Scilit:

• From Pharmacogenetics to Personalized Medicine: A vital Need for Educating Health Professionals and the Community
  Pharmacogenomics, 2004
• Personalized psychiatry: a realistic goal
  Pharmacogenomics, 2004
• Pharmacogenomics in anticoagulant drug development
  Pharmacogenomics, 2002
• Differential effects of 2C9*3 and 2C9*2 variants of cytochrome P-450 CYP2C9 on sensitivity to acenocoumarol
  Blood, 2002
• Association Between CYP2C9 Genetic Variants and Anticoagulation-Related Outcomes During Warfarin Therapy
  JAMA, 2002
• Cytochrome P4502C9 (CYP2C9) allele frequencies in Canadian Native Indian and Inuit populations
  Canadian Journal of Physiology and Pharmacology, 2001
• Pharmacogenomics: The Inherited Basis for Interindividual Differences in Drug Response
  Annual Review of Genomics and Human Genetics, 2001
• Rapid Detection of CYP2C9*3 Alleles by Real-Time Fluorescence PCR Based on SYBR Green
  Molecular Genetics and Metabolism, 1999
• Pharmacogenomics: Translating Functional Genomics into Rational Therapeutics
  Science, 1999
• Genetic Polymorphism of Cytochrome P450s, CYP2C19, and CYP2C9 in a Japanese Population
  Therapeutic Drug Monitoring, 1998